Skip to main content

Overview

Dr. Liu is committed to advancing our understanding of mechanisms of arrhythmias and novel approaches to catheter ablation. His recent work has aimed at evaluating the utility of dominant frequency analysis as a method to identify areas of complex fractionated electrograms (CFEs) in the human left atrium during atrial fibrillation. CFE areas may be important in sustaining persistent atrial fibrillation and thus have become target for catheter ablation of this arrhythmia; Dr. Liu's work suggests that the dominant frequency map can identify additional areas of CFE which are not detected by the conventional method. In addition, Dr. Liu is pursuing improvement in the integration of advanced imaging technologies such as intracardiac echocardiography and rotational angiography into complex ablation procedures for atrial fribrillation and ventricular tachycardia. Dr. Liu has co-authored several manuscripts in respected cardiology journals, and his recent findings were presented at the Annual Scientific Sessions of the Heart Rhythm Society. He is a member of the Heart Rhythm Society and the American College of Cardiology.

Highlights

  1. 1
    Heart rhythm · 2024
    PMID: 39326511PMCID: PMC11700763DOIFirst author5 citations
  2. 2
    Heart rhythm · 2024
    PMID: 38574785DOIFirst author17 citations
  3. 3
    Heart rhythm · 2024
    PMID: 38772432DOIFirst author15 citations

Publications

122 publications

Funding

2 grants
Completed grants (2)
  • Co-I
    Soft robotic sensor arrays for fast and efficient mapping of cardiac arrhythmias.
    National Heart, Lung, and Blood Institute · 2023–2025 · via Contour Medical INC
    R43HL170872-01
  • Co-I
    Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
    National Heart, Lung, and Blood Institute · 2021–2025
    R33HL156153-03

Clinical research

6 studies

Active

2 studies
  • PI
    Machine learning for automated isthmus detection in ventricular tachycardias
    Columbia University · OPEN TO ACCRUAL (as of 2025)
  • PI
    The Fourth Left Atrial Appendage Occlusion Study (LAAOS-4)
    NA · Population Health Research Institute · OPEN TO ACCRUAL (as of 2025)
    Atrial Fibrillation; Stroke, Ischemic; Systemic Embolism
    NCT05963698
Completed & closed trials (4)
  • PI
    Assessment of Safety and Effectiveness in Treatment Management of Paroxysmal Atrial Fibrillation With the BWI Pulsed Field Ablation System With OMNYPULSE™ Catheter
    NA · Biosense Webster, Inc. · CLOSED TO ACCRUAL (as of 2026)
    Atrial Fibrillation
    NCT06455098
  • PI
    BIOTRONIK Conduction System Pacing With the Solia Lead
    NA · BIOTRONIK, Inc. · CLOSED TO ACCRUAL (as of 2026)
    Bradycardia; Atrioventricular Block; Left Bundle-Branch Block; Cardiomyopathies
    NCT05251363
  • PI
    Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System (AdmIRE)
    NA · Biosense Webster, Inc. · IRB STUDY CLOSURE (as of 2024)
    Atrial Fibrillation
    NCT05293639
  • PI
    Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation (PVI) in Subjects With PAF
    NA · Biosense Webster, Inc. · IRB STUDY CLOSURE (as of 2022)
    Paroxysmal Atrial Fibrillation
    NCT03775512

External relationships

Other

BIOTRONIK GmbH & Co.